Complementary and Alternative Medicine is a sociological investigation of complementary and alternative medicine (CAM) in contemporary society, and an exploration of the forces throughout the globe, across different institutions, and within different therapeutic spaces, that constrain or foster alternative medicine. Drawing on 30 years of research, the book identifies the trends in the use of CAM and explores the scientific, political and social challenges that CAM faces in relation to orthodox medicine. The author examines the varieties of CAM practices and how they manifest in different institutional spaces – including public inquiries, the orthodox medical practitioner’s consulting room, medical journals and the homes of those who use CAM. It also compares unorthodox practices in different geo-political settings, namely the global north and the global south. This book is valuable reading for higher-level undergraduate and postgraduate social science students, including those in psychology, sociology, anthropology, health sciences and related disciplines. It is relevant for courses in medical sociology, medical anthropology and social science and health, and a broader audience interested in contemporary health issues, controversies and alternative medicine.

Integration of complementary and alternative medicine therapies (CAM) with conventional medicine is occurring in hospitals and physicians offices, health maintenance organizations (HMOs) are covering CAM therapies, insurance coverage for CAM is increasing, and integrative medicine centers and clinics are being established, many with close ties to medical schools and teaching hospitals. In determining what care to provide, the goal should be comprehensive care that uses the best scientific evidence available regarding benefits and harm, encourages a focus on healing, recognizes the importance of compassion and caring, emphasizes the centrality of relationship-based care, encourages patients to share in decision making about therapeutic options, and promotes choices in care that can include complementary therapies where appropriate. Numerous approaches to delivering integrative medicine have evolved. Complementary and Alternative Medicine in the United States identifies an urgent need for health systems research that focuses on identifying the elements of these models, the outcomes of care delivered in these models, and whether these models are cost-effective when compared to conventional practice settings. It outlines areas of research in convention and CAM therapies, ways of integrating these therapies, development of curriculum that provides further education to health professionals, and an amendment of the Dietary Supplement Health and Education Act to improve quality, accurate labeling, research into use of supplements, incentives for privately funded research into their efficacy, and consumer protection against all potential hazards.

Rare diseases collectively affect millions of Americans of all ages, but developing drugs and medical devices to prevent, diagnose, and treat these conditions is challenging. The Institute of Medicine (IOM) recommends implementing an integrated national strategy to promote rare diseases research and product development.

The revised edition of this award-winning book offers thirty-three Neuro Updates, which provide evidence-based data to help you recognize and explain the deeply transformational nature of the work. Expanding the Practice of Sex Therapy looks beyond behavioral treatments, pharmaceutical interventions, and performance goals to a comprehensive picture of what your clients want and need when they enter sex therapy, and offers creative ways to engage your clients in their own therapeutic process, whether or not you are trained as a sex therapist. Central to Gina Ogden’s approach is her Four-Dimensional Wheel of Sexual Experience, an innovative template that recognizes the full range of sexual issues: physical, emotional, mental, and spiritual. The text is organized into five practice-oriented sections that introduce the 4-D Wheel; show you how you can use it with individuals, couples, and groups; and encourage you to explore it on your own.

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

At the last Annual Representative Meeting of the British Medical Association a motion was passed that `certain additional cannabinoids should be legalized for wider medicinal use.'' This report supports this landmark statement by reviewing the scientific evidence for the therapeutic use of cannabinoids and sets the agenda for change. It will be welcomed by those who believe that cannabinoids can be used in medical treatment. The report discusses in a clear and readable form the use and adverse effects of the drug for nausea, multiple sclerosis, pain, epilepsy, glaucoma, and asthma.

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.

All losses are touched with ambiguity. Yet those who suffer losses without finality bear a particular burden. Pauline Boss, the principal theorist of the concept of ambiguous loss, guides clinicians in the task of building resilience in clients who face the trauma of loss without resolution. Boss describes a concrete therapeutic approach that is at once directive and open to the complex contexts in which people find meaning and discover hope in the face of ambiguous losses. In Part I readers are introduced to the concept of ambiguous loss and shown how such losses relate to concepts of the family, definitions of trauma, and capacities for resilience. In Part II Boss leads readers through the various aspects of and target points for working with those suffering ambiguous loss. From meaning to mastery, identity to ambivalence, attachment to hope–these chapters cover key states of mind for those undergoing ambiguous loss. The Epilogue addresses the therapist directly and his or her own ambiguous losses. Closing the circle of the therapeutic process, Boss shows therapists how fundamental their own experiences of loss are to their own clinical work. In Loss, Trauma, and Resilience, Boss provides the therapeutic insight and wisdom that aids mental health professionals in not "going for closure," but rather building strength and acceptance of ambiguity. What readers will find is a concrete therapeutic approach that is at once directive and open to the complex contexts in which people find meaning and discover hope in the face of ambiguous losses.